Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-016629
Filing Date
2023-03-07
Accepted
2023-03-07 14:04:22
Documents
1
Period of Report
2023-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3429
  Complete submission text file 0001209191-23-016629.txt   4868
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
Friedl-Naderer Johanna (Reporting) CIK: 0001915598 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 23712064